Posts by: Patricia Silva, PhD

Patricia Silva, PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

May 21, 2015November 9, 2015

Boehringer’s Drug Combination Therapy For COPD Promotes Lung Function Improvement in Patients

COPD, News

Boehringer Ingelheim Pharmaceuticals, Inc. recently announced new data from the pivotal Phase III TONADO™ 1&2 studies (NCT01431274 and NCT01431287), regarding the efficacy and safety of its investigational product tiotropium/olodaterol delivered via ... Read more

May 19, 2015November 5, 2015

Boehringer’s Idiopathic Pulmonary Fibrosis Therapy OFEV Shown To Be Safe, Effective in Longer-Term Study

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim recently announced new data on OFEV® (nintedanib) that further supports its efficacy, tolerability and safety in patients with idiopathic pulmonary fibrosis (IPF). The results were presented at the American ... Read more

May 18, 2015November 9, 2015

Patient Quality of Life Found To Be a Reliable Predictor of Medical Costs Related to COPD Care

COPD, News

A new study recently published in the journal Health and Quality of Life Outcomes revealed that in China, the quality of life of patients with chronic obstructive pulmonary disease (COPD) ... Read more

May 15, 2015November 5, 2015

Actelion’s Encouraging Clinical Trial Results on PAH Therapies to be Presented at Upcoming Scientific Meeting

News, Pulmonary Hypertension

Actelion Pharmaceuticals Ltd recently announced in a press release that data from its Phase III trials on the drugs selexipag (Uptravi) and macitentan (Opsumit) will be presented at the upcoming ... Read more

May 14, 2015November 6, 2015

Researchers Report Encouraging Results in Treating Pulmonary Non-Tuberculous Mycobacteria With Liposomal Ciprofloxacin

Bronchiectasis, News

Researchers at Oregon State University, Corvallis (OSU) and pharmaceutical company Aradigm Corporation have found that Aradigm’s investigational products Lipoquin® and Pulmaquin® are capable of significantly reducing the growth of the ... Read more

May 11, 2015November 9, 2015

Protein Found to Play a Key Role in COPD-Related Lung Damage Due to Cigarette Smoke and Viral Infection

COPD, Emphysema, News

Researchers at Yale University in Connecticut and Brown University in Rhode Island recently discovered that a particular protein called interleukin-15 (IL-15) plays a key role in the induction of lung damage caused by cigarette ... Read more

May 7, 2015November 5, 2015

Parion’s Phase 2 Clinical Trial for a Cystic Fibrosis Treatment is Currently Enrolling Participants

Cystic Fibrosis, News

Biopharmaceutical company Parion Sciences recently announced the start of the enrollment process for a Phase 2 clinical trial of its product P-1037, a therapy for cystic fibrosis (CF). The trial is called ... Read more

May 5, 2015November 9, 2015

Cigarette Smoke Analysis Leads To Potential Therapeutic Target For COPD

COPD

A new study led by researchers at Yale School of Medicine in Connecticut and Brown University in Rhode Island recently revealed that cigarette smoke interferes with a specific protein that ... Read more

May 4, 2015May 4, 2015

Researchers Propose PEI Regimen as a Therapeutic Option for Small Cell Lung Cancer

Lung Cancer, News

Researchers at the Azienda Ospedaliera Santa Maria Nuova / IRCCS of Reggio Emilia in Italy recently reported in the Journal of Translational Medicine that a chemotherapeutic treatment based on cisplatin, etoposide ... Read more

April 30, 2015April 30, 2015

Post-Surgical Lung Cancer Patients Reported to Have an Increased Risk for Thromboembolism

Lung Cancer, News

Three studies were recently presented at the 95th Annual Meeting of the American Association for Thoracic Surgery addressing the issue of venous thromboembolism (VTE) after lung cancer surgery. VTE refers to ... Read more